Deciding who should be treated for hepatitis C infection in a rapidly changing therapeutic landscape

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|1|13-15

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.1, 2015-07, pp. : 13-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 660-661

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis C Virus Infection in Haemodialysis: The ‘No-Isolation’ Policy Should Not Be Generalized

By  

Nephron Clin Pract, Vol. 111, Iss. 2, 2009-01 ,pp. : c133-c140

Karger

Access to resources Recommend Favorite

Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan

By  

Intervirology, Vol. 53, Iss. 1, 2010-01 ,pp. : 39-43

Karger

Access to resources Recommend Favorite

Burden of HIV and hepatitis C co‐infection: the changing epidemiology of hepatitis C in HIV‐infected patients in France

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 65-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Rapidly Changing Oncology Landscape: A Time for Transition in Oncology

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 417-418

Karger

Access to resources Recommend Favorite